Q2 FY26 earnings calls.

Aarti Drugs reported a solid Q2 FY26 with consolidated revenue of ₹652.9 crore (+9% YoY) and EBITDA of ₹84.4 crore (+23% YoY), driven by robust export volume growth of over 30% which offset weak domestic antibiotic deman

Aavas Financiers reported a strong Q2 FY26 with PAT of ₹164 crore, up 11% YoY, driven by robust NII growth of 18% YoY and improved spreads. Disbursements grew 36% QoQ and 21% YoY to ₹15.6 billion, recovering from Q1's re

ABB India reported 14% YoY revenue growth in Q3 FY2025-26, driven by a 13% base order growth across divisions, though total orders fell 3% due to absence of large contracts. Profit after tax declined 7% YoY, with margins

Acme Solar reported a stellar Q2 FY26 with revenue of 601 crore (up 104% YoY) and EBITDA of 534 crore (up 180% YoY), driven by capacity additions and operational efficiencies. EBITDA margin expanded to 89% from 87% last

Adani Enterprises reported H1 FY26 consolidated total income of INR 44,281 crore and EBITDA of INR 7,688 crore, with incubating businesses contributing over 70% of EBITDA (up from 60% YoY). The airport vertical posted st

Adani Green Energy delivered a strong H1 FY26, with revenue from power supply up 26% YoY to INR 6,088 crore and EBITDA up 25% to INR 5,651 crore, driven by a 39% increase in energy sales to 19.6 billion units and capacit

Adani Power reported Q2 FY26 continuing revenue of INR 13,639 crore, up ~1% YoY, with EBITDA of INR 5,325 crore and PAT of INR 2,906 crore. Power sales grew 7% to 23.7 BU, but PLF fell to 62.8% due to an extended monsoon

Adani Total Gas delivered a solid Q2 FY26 with revenue of INR 1,569 crore (+19% YoY) and EBITDA of INR 302 crore, driven by 16% volume growth (CNG +18%, PNG +11%). The company crossed 1 million household PNG connections

APSEZ delivered a record Q2FY26 with revenue of ₹9,167 crore (+30% YoY), EBITDA of ₹5,550 crore (+27% YoY), and PAT of ₹3,120 crore (+29% YoY). Domestic ports achieved a record H1 EBITDA margin of 74.2% and market share

Aditya Birla Capital reported a 3% YoY PAT growth to INR 855 crore in Q2 FY26, with consolidated revenue up 4% YoY to INR 12,481 crore. The NBFC segment saw record disbursements of INR 21,990 crore (up 39% QoQ) and a 22%

ABFRL reported Q2 FY26 revenue of INR 1,900.82 crore, up 13% YoY, driven by double-digit growth in Ethnic, Luxury, and TMRW segments. Pantaloons grew 6% with 7% like-for-like growth, aided by early Pujo but partially off

ABFRL reported Q2 FY26 revenue of ₹1,908 crore, up 13% YoY, driven by strong like-to-like growth across segments. EBITDA margin contracted 30bps to 5.9% due to higher marketing investments (up 200bps YoY). PAT loss widen

ABLBL reported Q2 FY26 revenue of ₹3,238 crore, up 4% YoY, with EBITDA of ₹338 crore (margin 16.6%, +125bps YoY). PAT was ₹23 crore vs a loss of ₹59 crore last year (which included a ₹98 crore exceptional). Growth was dr

Aditya Birla Real Estate reported strong Q2 FY26 bookings of ₹890 crore, up 111% QoQ, driven by flagship projects Birla Niara and Birla Alia. Despite no new launches, operational traction remained healthy with 80% of tot

Afcons reported Q2 FY26 revenue of ₹3,101 crore (flat YoY) and EBITDA of ₹401 crore (margin 12.9%, down 10bps YoY). PAT fell 22% to ₹105 crore due to a ~₹100 crore exceptional provision. H1 revenue grew 3.4% to ₹6,520 cr

Affle delivered a record quarter with revenue of ₹646.7 crore (+19.1% YoY), EBITDA of ₹146.1 crore (+28.9% YoY), and PAT of ₹115 crore (+20.1% YoY). EBITDA margin expanded 172 bps YoY to 22.6%, marking the sixth consecut

AIA Engineering reported steady Q2 FY26 results with revenue of INR 1,029 crore, EBITDA of INR 395 crore, and PAT of INR 277 crore, driven by stable volumes of 63,000 tons. The key highlight is a breakthrough 18-month co

Ajanta Pharma delivered a strong Q2 FY26 with consolidated revenue of ₹1,354 crore (+14% YoY) and PAT of ₹260 crore (+20% YoY). Growth was led by US generics (+48% YoY to ₹343 crore) benefiting from recent product launch

Ajanta Pharma delivered a strong Q2 FY26 with revenue of INR 1,354 crore (+14% YoY) and PAT of INR 260 crore (+20% YoY). Growth was led by the US generics business (+48% YoY to INR 343 crore) benefiting from recent launc

Alivus Life Sciences reported a strong Q2 FY26 with revenue of ₹588 crore (up 16% YoY) and EBITDA margin of 33% (up 480 bps YoY), driven by a 39.7% growth in non-GPL API business and new product launches. Gross margin im

Alkem delivered a strong Q2 FY26 with revenue of INR 4,001 crore (+17.2% YoY), EBITDA of INR 921 crore (+22.3% YoY), and PAT of INR 765 crore (+11.1% YoY). India business grew 12.4% YoY, US sales surged 28% YoY driven by

Alkem delivered a strong Q2 FY26 with revenue of ₹4,010 crore (+17.2% YoY), driven by robust growth across India (+12.4%), US (+28%), and non-US markets (+32.4%). EBITDA margin improved to 23% (+22.3% YoY), aided by oper

Allcargo Logistics reported a solid Q2 FY26 with consolidated revenue of ₹537 crore (+11% YoY) and EBITDA of ₹62 crore (+27% YoY), driven by record performance in both express and contract logistics. Express business ach

Allied Blenders delivered a strong Q2 FY26 with consolidated revenue of ₹995 crore (+14.4% YoY), EBITDA of ₹130 crore (+23.6% YoY), and PAT of ₹63 crore (+32.3% YoY). Growth was driven by premiumization, with the PNA seg

Amara Raja's Q2 FY26 consolidated revenue grew 6.5% YoY to ₹3,467 crore, driven by 30% YoY growth in OEM volumes for lead-acid batteries, while aftermarket remained flat due to GST-related disruptions. The new energy bus

Ambuja Cements delivered a robust Q2 FY26 with consolidated revenue of ₹9,174 crore (+21% YoY) and EBITDA of ₹1,761 crore (+58% YoY), driven by record sales volume of 16.6 million tons (+20% YoY) and cost reductions. EBI

Anand Rathi reported Q2 FY26 consolidated revenue of ₹227.2 crore, EBITDA of ₹92.6 crore (margin 40.8%), and PAT of ₹27.9 crore, all showing strong sequential growth of 13%, 24%, and 22% respectively. The non-broking seg

Anand Rathi Wealth delivered a strong Q2 FY26 with revenue of ₹307 crore (+23% YoY) and PAT of ₹99.89 crore (+31% YoY), marking the 16th consecutive quarter of consistent performance despite a 34% Nifty decline. Key driv

Angel One reported a healthy Q2 FY26 with gross revenues of ₹12B, up 5.3% QoQ, and PAT of ₹2.1B, up 85% QoQ (normalized PAT up 10.1% QoQ). EBITDA margin improved to 34.5% (normalized 34.5%), aided by absence of IPL expen

Apar Industries reported a strong Q2 FY26 with consolidated revenue of ₹5,715 crore (+23.1% YoY) and EBITDA of ₹499 crore (+24% YoY), driven by volume growth across all divisions and a 43% surge in exports. The conductor

APAR Industries reported a strong Q2 FY26 with consolidated revenue of INR 5,715 crores (+23.1% YoY), EBITDA of INR 499 crores (+24% YoY), and PAT of INR 252 crores (+30% YoY). Growth was driven by volume expansion acros

Apex Frozen Foods delivered a strong Q2 FY26 with revenue of ₹238 crore (+19% YoY) driven by higher realizations of ₹870/kg (+25% YoY). EBITDA surged 284% YoY to ₹18 crore, with margin expanding to 7.2% (vs 2.3% last yea

APL Apollo reported its highest-ever quarterly volume of 850,000 tons and EBITDA per ton of 5,200 rupees in Q2 FY26, driven by brand premiumization, value-added mix improvement from Raipur and Dubai plants, and operating

Apollo Hospitals delivered a solid Q2 FY26 with consolidated revenue of INR 6,304 crore (+13% YoY) and EBITDA of INR 941 crore (+15% YoY). Healthcare services revenue grew 9% to INR 3,169 crore, driven by a 14% increase

Apollo Hospitals reported a strong Q2 FY26 with consolidated revenue of ₹6,634 crore (up 13% YoY) and EBITDA of ₹941 crore (up 15% YoY). Healthcare services revenue grew 9% to ₹3,169 crore, driven by a 14% increase in re

Apollo Micro Systems delivered a stellar Q2 FY26 with revenue of ₹225 crore, up 69% QoQ, and PAT of ₹30 crore, up 70% QoQ, driven by robust order book execution and transition of multiple products into production. EBITDA

EMS Limited reported a weak Q2 FY26 due to heavy monsoon rains across its six operating states, which halted underground digging and pipeline works. Revenue declined approximately 26-27% versus the prior quarter, though

Apollo Tyres reported a solid Q2 FY26 with consolidated revenue of INR 68.3 billion (+6% YoY) and EBITDA margin of 14.9% (+130 bps YoY), driven by strong India performance and recovery in exports. India revenue grew 6% t

Archean Chemical's Q2 FY26 consolidated revenue declined 8% YoY to ₹239.6 crore, with EBITDA down 15% to ₹69 crore, reflecting a 28.8% margin. The miss was driven by lower bromine production due to technical issues and p

Arvind Fashions delivered another quarter of double-digit revenue growth, with revenue up 11.3% YoY to ₹1,418 crore and EBITDA up 18.2% to ₹200 crore, marking the highest ever sales and EBITDA. Growth was driven by stron

Ashok Leyland reported a strong Q2 FY26 with revenue of INR 9,588 crore (+9.3% YoY) and record EBITDA of INR 1,162 crore (+14.2% YoY), with EBITDA margin expanding 50bps to 12.1%. PAT stood at INR 771 crore. Growth was d

Ashoka Buildcon's Q2 FY26 consolidated revenue fell 35% YoY to ₹1,198 crore, impacted by extended monsoons and project delays. EBITDA declined 32% YoY to ₹642 crore, though margins improved to 33.6% due to asset sales. P

Asian Paints delivered a strong Q2 FY26 with consolidated net sales growing 6.4% YoY and PBDIT up 21.3% YoY, driven by a 10.9% volume growth in decorative paints. The company's strategic initiatives—including regional ma

Astral delivered a strong Q2 FY2026 with 20% volume growth and 15% value growth, driven by new plant ramp-ups (Hyderabad, Kanpur), improved product mix toward value-added items, and aggressive market share gains despite

Ather Energy delivered a strong Q2 FY26 with total income of ₹940 crore (up 57% YoY) and EBITDA margin improving to -10% (up 1100 bps YoY), driven by record unit sales of 66,000 units (up 67% YoY) and market share expans

AU Small Finance Bank reported a resilient Q2 FY26 with PAT of ₹561 crore and H1 PAT of ₹1,142 crore, up 6% YoY. Core secured loan growth was 22% YoY, while total loan growth moderated to 17% due to deliberate unsecured

AU Small Finance Bank reported Q2 FY26 PAT of ₹561 crore, with NIM expanding 5 bps QoQ to 5.5% and credit cost declining to ₹481 crore. Core secured loan growth was 22% YoY, while unsecured book degrew 23% YoY. Deposits

Aurobindo Pharma reported Q2 FY26 consolidated revenue of INR 8,286 crore (+6% YoY) and EBITDA of INR 1,678 crore (20.3% margin, +7% YoY). PAT stood at INR 848 crore. Growth was driven by strong US formulation (6% QoQ ex